Prime Medicine, Inc. (NYSE:PRME – Get Free Report) gapped down before the market opened on Wednesday after Chardan Capital lowered their price target on the stock from $17.00 to $15.00. The stock had previously closed at $4.32, but opened at $4.03. Chardan Capital currently has a buy rating on the stock. Prime Medicine shares last […]